a
Cardiovascular and Gastrointestinal Innovative Medicines Unit, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire, UK
E-mail: Philip.MacFaul@astrazeneca.com
;
Tel: +44 (0)1625 516080
b
Medicines Evaluation CNSP, Pharm. Dev., AstraZeneca R&D Södertälje, 151 85 Södertälje, Sweden
c
School of Chemical Science and Engineering, Royal Institute of Technology, Teknikringen 30, 100 44 Stockholm, Sweden
d
Department of Chemistry, University of Huddersfield, Queensgate, Huddersfield West Yorkshire, UK